ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,299Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 1111

$885K Total Retail Price of All Prescriptions

Rank: 60 out of 1111

423 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 12,670 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 761 479 S3 1 1
OMEPRAZOLE 476 408 2 4
SIMVASTATIN 475 382 3 5
FUROSEMIDE 449 399 4 6
POTASSIUM CHLORIDE 386 329 5 9
LISINOPRIL 377 305 6 2
CITALOPRAM HBR 338 286 7 14
LEVOTHYROXINE SODIUM 316 282 8 3
GABAPENTIN 316 252 8 10
METFORMIN HCL 287 250 10 8
NAMENDA 261 254 11 31
DONEPEZIL HCL 252 243 12 25
CARVEDILOL 250 211 13 21
FLUTICASONE PROPIONATE 220 161 14 27
WARFARIN SODIUM 216 192 15 19
RISPERIDONE 213 182 16 60
POLYETHYLENE GLYCOL 3350 213 184 16 45
TRAMADOL HCL 209 166 18 13
AMLODIPINE BESYLATE 202 171 19 7
TRAZODONE HCL 195 144 20 32
METOPROLOL TARTRATE 191 171 21 12
METOPROLOL SUCCINATE 183 145 22 20
HYDROCHLOROTHIAZIDE 163 126 23 11
RANITIDINE HCL 148 103 24 29
NEXIUM 147 132 25 26
CIPROFLOXACIN HCL 139 108 26 58
DIVALPROEX SODIUM 137 126 27 82
QUETIAPINE FUMARATE 135 90 28 76
FAMOTIDINE 132 99 29 77
ISOSORBIDE MONONITRATE ER 124 111 30 73
TAMSULOSIN HCL 123 97 31 28
MELOXICAM 121 95 32 18
LANTUS 118 85 33 46
SERTRALINE HCL 113 79 34 24
FLUOXETINE HCL 111 77 35 44
CLONIDINE HCL 109 91 36 42
AZITHROMYCIN 108 83 37 39
ATORVASTATIN CALCIUM 107 93 38 15
ATENOLOL 107 94 38 22
MIRTAZAPINE 104 89 40 52
SPIRIVA 99 59 41 53
BISOPROLOL-HYDROCHLOROTHIAZIDE 97 79 42 143
PROAIR HFA 96 56 43 38
MEGESTROL ACETATE 95 71 R 44 103
SUCRALFATE 87 69 45 125
NAPROXEN 86 73 46 85
CYMBALTA 85 57 47 40
ROPINIROLE HCL 84 64 48 68
CLOPIDOGREL 79 55 49 30
METHYLPREDNISOLONE 78 51 50 93
LEVOXYL 78 60 50 223
ESCITALOPRAM OXALATE 78 65 50 78
DIGOXIN 78 76 50 47
PANTOPRAZOLE SODIUM 73 54 54 50
CARBIDOPA-LEVODOPA 73 72 54 101
NOVOLOG 71 53 56 104
METOCLOPRAMIDE HCL 69 42 57 130
EXELON 68 68 58 121
PREDNISONE 67 58 59 48
ZOLPIDEM TARTRATE 67 45 59 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 51 59 71
GLYBURIDE 65 42 R 62 59
CARISOPRODOL 64 31 R 63 54
NOVOLIN 70-30 63 55 64 262
JANUVIA 62 47 65 75
SEROQUEL 61 49 66 170
QUINAPRIL HCL 61 38 66 213
IBUPROFEN 59 23 68 66
PLAVIX 58 38 69 49
ALLOPURINOL 57 55 70 36
CARAFATE 57 22 70 330
GLIPIZIDE 56 48 72 57
LEVOFLOXACIN 56 37 72 88
VENLAFAXINE HCL ER 55 43 74 105
NAPROXEN SODIUM 55 15 74 402
PAROXETINE HCL 55 34 74 55
RIVASTIGMINE 54 54 77 359
HUMULIN 70-30 53 34 78 251
ADVAIR DISKUS 53 37 78 43
PRAVASTATIN SODIUM 52 31 80 17
OXYBUTYNIN CHLORIDE ER 52 44 80 114
OLANZAPINE 51 20 82 117
LOSARTAN POTASSIUM 51 35 82 34
ENALAPRIL MALEATE 50 37 84 56
BACLOFEN 50 0 84 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.